Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Cytosorbents Cor
(NQ:
CTSO
)
0.8190
+0.0100 (+1.24%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Apr 26, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
96,079
Open
0.8000
Bid (Size)
0.7952 (11)
Ask (Size)
0.8642 (11)
Prev. Close
0.8090
Today's Range
0.8000 - 0.8199
52wk Range
0.7820 - 4.290
Shares Outstanding
54,293,555
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
CytoSorbents to Report First Quarter 2024 Operating and Financial Results
Today 7:00 EDT
From
CytoSorbents
Via
GlobeNewswire
STAR-T Pivotal Trial Results to Be Featured as a Late-Breaking Presentation at the 2024 American Association for Thoracic Surgery Annual Meeting
April 17, 2024
From
CytoSorbents
Via
GlobeNewswire
Performance
YTD
-23.46%
-23.46%
1 Month
-11.93%
-11.93%
3 Month
-17.27%
-17.27%
6 Month
-46.47%
-46.47%
1 Year
-66.71%
-66.71%
More News
Read More
CTSO Stock Earnings: CytoSorbents Beats EPS, Misses Revenue for Q4 2023
March 14, 2024
Via
InvestorPlace
Recap: CytoSorbents Q4 Earnings
March 14, 2024
Via
Benzinga
A Preview Of CytoSorbents's Earnings
March 13, 2024
Via
Benzinga
What To Know About HC Wainwright & Co.'s Downgrade of CytoSorbents
December 29, 2023
Via
Benzinga
Recap: CytoSorbents Q3 Earnings
November 09, 2023
Via
Benzinga
CytoSorbents Reports Fourth Quarter and Full Year 2023 Results
March 14, 2024
From
CytoSorbents
Via
GlobeNewswire
Earnings Scheduled For March 14, 2024
March 14, 2024
Via
Benzinga
CytoSorbents to Report Fiscal 2023 Operating and Financial Results
March 06, 2024
From
CytoSorbents
Via
GlobeNewswire
CytoSorbents to Present at the TD Cowen 44th Annual Health Care Conference
February 08, 2024
From
CytoSorbents
Via
GlobeNewswire
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
January 17, 2024
Via
Benzinga
Groundbreaking Randomized Controlled Trial Reports Excellent Clinical Outcomes Using CytoSorb® Intraoperatively in Heart Transplant Patients
January 17, 2024
From
CytoSorbents
Via
GlobeNewswire
CYTOSORBENTS ALERT: Bragar Eagel & Squire, P.C. is Investigating Cytosorbents Corporation on Behalf of Cytosorbents Stockholders and Encourages Investors to Contact the Firm
January 08, 2024
From
Bragar Eagel & Squire
Via
GlobeNewswire
Gold Moves Lower; US Crude Stocks Decline Last Week
December 28, 2023
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Why DouYu International Shares Are Trading Higher By 14%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
December 28, 2023
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
December 28, 2023
Via
Benzinga
Crude Oil Down 1%; US Wholesale Inventories Fall In November
December 28, 2023
Via
Benzinga
Topics
Stocks
Exposures
Fossil Fuels
US Equities
Dow Gains 50 Points; US Jobless Claims Rise To 218,000
December 28, 2023
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Why Is Blood Purification Focused CytoSorbents Trading Lower Today?
December 28, 2023
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
December 28, 2023
Via
Benzinga
CytoSorbents Provides Update on the STAR-T Trial and Reports Final Independent Data and Safety Monitoring Board Recommendation
December 28, 2023
From
CytoSorbents
Via
GlobeNewswire
CytoSorbents Announces Closing of $10.3 Million Registered Direct Offering
December 13, 2023
From
CytoSorbents
Via
GlobeNewswire
12 Health Care Stocks Moving In Friday's Pre-Market Session
November 17, 2023
Via
Benzinga
CytoSorbents Reports Third Quarter 2023 Financial and Operational Results
November 09, 2023
From
CytoSorbents
Via
GlobeNewswire
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.